Page 1

For personal use only INMACH7 ASX Announcement First Quarter FY22 Business Update Highest Quarterly Sales Orders on Record CARR Increases to $ 16.8M Q1 Highlights : Sales orders $ 16.2M ( TCV ) ; up 368 % on last quarter ( Q4'21 $ 4.4M ) ◆ Major expansion contract wins secured from Trinity Health and Advocate Aurora Healthcare ◆ Contracted annual recurring revenue ( CARR ) $ 16.8M ; up 6 % or 24 % annualized ( Q4'21 $ 15.8M ) ◆ Cash on hand $ 17.2M ; ( 30 June 2021 $ 18.4M ) Melbourne , Australia ; 18 October 2021 : Mach7 Technologies Limited ( “ Mach7 ” or the " Company " ) ( ASX : M7T ) , a company specialising in innovative medical imaging solutions for healthcare providers , is pleased to provide this quarterly update in conjunction with the release of the Appendix 4C - Quarterly Cash Flow Report . Sales Orders The Company landed several major sales orders this quarter , totaling $ 16.2 million , Mach7's strongest quarterly sales order result on record and 368 % up on the prior quarter . With this result , sales have already reached 63 % of last year's full year orders of $ 25.6 million , with three quarters of the year to go . Sales Orders ( TCV ) Since Listing Quarterly Sales Orders Growth FY 16 FY 17 FY 18 FY 19 FY 20 FY 21 Q1 22 Mach7 Technologies Limited ABN 26 007 817 192 ASX : M7T 30.0 M 18.0 M 16.0 M 25.0 M 14.0 M 12.0 M 20.0 M 10.0 M 15.0 M 8.0 M 6.0 M 10.0 M 4.0 M 2.0 M 5.0 M 0.0 M 0.0 M .... Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2020 2020 2020 2020 2021 2021 2021 2021 2022 MACH7T.COM